rs2127565

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138715.3(MSR1):​c.1034-8444G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.725 in 151,916 control chromosomes in the GnomAD database, including 42,871 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 42871 hom., cov: 31)

Consequence

MSR1
NM_138715.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0160
Variant links:
Genes affected
MSR1 (HGNC:7376): (macrophage scavenger receptor 1) This gene encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of this gene. These receptors or isoforms are macrophage-specific trimeric integral membrane glycoproteins and have been implicated in many macrophage-associated physiological and pathological processes including atherosclerosis, Alzheimer's disease, and host defense. The isoforms type 1 and type 2 are functional receptors and are able to mediate the endocytosis of modified low density lipoproteins (LDLs). The isoform type 3 does not internalize modified LDL (acetyl-LDL) despite having the domain shown to mediate this function in the types 1 and 2 isoforms. It has an altered intracellular processing and is trapped within the endoplasmic reticulum, making it unable to perform endocytosis. The isoform type 3 can inhibit the function of isoforms type 1 and type 2 when co-expressed, indicating a dominant negative effect and suggesting a mechanism for regulation of scavenger receptor activity in macrophages. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.866 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MSR1NM_138715.3 linkuse as main transcriptc.1034-8444G>C intron_variant ENST00000262101.10
MSR1NM_001363744.1 linkuse as main transcriptc.1088-8444G>C intron_variant
MSR1NM_138716.3 linkuse as main transcriptc.1033+14508G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MSR1ENST00000262101.10 linkuse as main transcriptc.1034-8444G>C intron_variant 1 NM_138715.3 P1P21757-1

Frequencies

GnomAD3 genomes
AF:
0.726
AC:
110165
AN:
151798
Hom.:
42859
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.422
Gnomad AMI
AF:
0.886
Gnomad AMR
AF:
0.726
Gnomad ASJ
AF:
0.824
Gnomad EAS
AF:
0.762
Gnomad SAS
AF:
0.770
Gnomad FIN
AF:
0.879
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.872
Gnomad OTH
AF:
0.763
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.725
AC:
110192
AN:
151916
Hom.:
42871
Cov.:
31
AF XY:
0.726
AC XY:
53956
AN XY:
74282
show subpopulations
Gnomad4 AFR
AF:
0.421
Gnomad4 AMR
AF:
0.726
Gnomad4 ASJ
AF:
0.824
Gnomad4 EAS
AF:
0.762
Gnomad4 SAS
AF:
0.771
Gnomad4 FIN
AF:
0.879
Gnomad4 NFE
AF:
0.872
Gnomad4 OTH
AF:
0.763
Alfa
AF:
0.791
Hom.:
5900
Bravo
AF:
0.699
Asia WGS
AF:
0.750
AC:
2601
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
2.0
DANN
Benign
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2127565; hg19: chr8-15986559; API